BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 18505742)

  • 1. Vascular effects of estrogen and progestins and risk of coronary artery disease: importance of timing of estrogen treatment.
    Gungor F; Kalelioglu I; Turfanda A
    Angiology; 2009; 60(3):308-17. PubMed ID: 18505742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hormone therapy on soluble cell adhesion molecules in postmenopausal women with coronary artery disease.
    Yeboah J; Klein K; Brosnihan B; Reboussin D; Herrington DM
    Menopause; 2008; 15(6):1060-4. PubMed ID: 18521047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The new conundrum: do estrogens have any cardiovascular benefits?
    Clarkson TB
    Int J Fertil Womens Med; 2002; 47(2):61-8. PubMed ID: 11991432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the controversy about hormonal replacement therapy: insights from estrogen effects on experimental and clinical atherosclerosis.
    Arnal JF; Douin-Echinard V; Tremollières F; Terrisse AD; Sié P; Payrastre B; Guery JC; Bayard F; Gourdy P
    Arch Mal Coeur Vaiss; 2007; 100(6-7):554-62. PubMed ID: 17893638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of hormone therapy on C-reactive protein and IL-6 in postmenopausal women: a review article.
    Lakoski SG; Herrington DM
    Climacteric; 2005 Dec; 8(4):317-26. PubMed ID: 16390766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogens, progestins, and coronary heart disease in cynomolgus monkeys.
    Clarkson TB
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):147S-151S. PubMed ID: 7958009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal supplement therapy in women: effects on the cardiovascular system].
    Maas AH; van Gilst WH; Verheugt FW
    Ned Tijdschr Geneeskd; 2001 Jan; 145(2):65-9. PubMed ID: 11225258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing hypothesis for postmenopausal hormone therapy: its origin, current status, and future.
    Clarkson TB; Meléndez GC; Appt SE
    Menopause; 2013 Mar; 20(3):342-53. PubMed ID: 23435033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Premature ovarian failure, endothelial dysfunction and estrogen-progestogen replacement.
    Kalantaridou SN; Naka KK; Bechlioulis A; Makrigiannakis A; Michalis L; Chrousos GP
    Trends Endocrinol Metab; 2006 Apr; 17(3):101-9. PubMed ID: 16515863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.
    Dubey RK; Imthurn B; Barton M; Jackson EK
    Cardiovasc Res; 2005 May; 66(2):295-306. PubMed ID: 15820198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease.
    Koledova VV; Khalil RA
    Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):777-89. PubMed ID: 17605655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The applicability of hormonal effects on atherosclerosis in animals to heart disease in postmenopausal women.
    Wagner JD; Clarkson TB
    Semin Reprod Med; 2005 May; 23(2):149-56. PubMed ID: 15852200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy and coronary artery disease.
    Morris D
    Curr Opin Obstet Gynecol; 1996 Jun; 8(3):184-7. PubMed ID: 8818528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormone therapy, C-reactive protein, and progression of atherosclerosis: data from the Estrogen Replacement on Progression of Coronary Artery Atherosclerosis (ERA) trial.
    Lakoski SG; Brosnihan B; Herrington DM
    Am Heart J; 2005 Nov; 150(5):907-11. PubMed ID: 16290959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention of coronary heart disease by early postmenopausal hormone therapy: new supporting data].
    Gaspard U
    J Gynecol Obstet Biol Reprod (Paris); 2008 Jun; 37(4):340-5. PubMed ID: 18249506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controversies about HRT--lessons from monkey models.
    Clarkson TB; Appt SE
    Maturitas; 2005 May; 51(1):64-74. PubMed ID: 15883111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hormone replacement therapy and coronary artery atherosclerosis: the monkey model.
    Clarkson TB; Anthony MS; Klein KP
    Br J Obstet Gynaecol; 1996 May; 103 Suppl 13():53-7; discussion 57-8. PubMed ID: 8624344
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.